Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUGUSTUS: Apixaban vs VKA and Aspirin vs Placebo in AF with ACS/PCI
NCT02415400Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), acute coronary syndrome (ACS), sponsored by Bristol Myers Squibb. Started Jun 2015; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02415400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415400.